BI and Harbin Veterinary Research Institute collaborate on exchange platform

Boehringer Ingelheim and Harbin Veterinary Research Institute have partnered on an exchange platform designed to train top-level global veterinary professionals, bringing together industry, academia and research, and promoting the sustainable development of the animal health industry in China. BI will deliver updates on global technology, compile talent training programmes and deliver lectures to help HVRI cultivate top global talent in the veterinary field. Together the companies will conduct in-depth exchanges in scientific research on the pathogen of swine diseases and related epidemics, main epidemic diseases in poultry, equine infectious leukemia, development and application of biological products for cattle and sheep, as well as zoonotic diseases.
Head of BI’s Animal Health in Greater China, Dr. Stephan Lange, said: “As a research-driven global leading animal health company, Boehringer Ingelheim is honoured to collaborate with Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences, which has strong research capabilities. We hope that both parties will contribute to the improvement of animal health and human health via talent development and scientific research exchanges, and boost the upgrading of China’s animal health industry. I believe that the establishment of this platform also deepens the scientific research exchanges and talent development cooperation in the veterinary fields between China and Germany.”
Director of HVRI, Dr. Bu Zhigao, said: “As the world’s leading animal health company, Boehringer Ingelheim has forward-looking insights and strong research and development capabilities. With this exchange platform, we expect to foster the integration of teaching, research and production, while cultivate postgraduates with international vision and innovate our R&D resources, thus effectively gearing up growth of China’s animal health industry.”